EC Healthcare Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van EC Healthcare is gedaald met een gemiddeld jaarlijks percentage van -39.3%, terwijl de winst van de Consumer Services -industrie jaarlijks groeide met 6.8%. De inkomsten zijn groeide met een gemiddeld percentage van 19.9% per jaar.

Belangrijke informatie

-39.3%

Groei van de winst

-42.4%

Groei van de winst per aandeel

Consumer Services Groei van de industrie	1.7%
Inkomstengroei	19.9%
Rendement op eigen vermogen	0.7%
Nettomarge	-0.4%
Volgende winstupdate	28 Nov 2024

Recente prestatie-updates uit het verleden

Recent updates

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

Nov 13

Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding

Sep 05

EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively

Jul 26

Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch

Dec 24

EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005

Dec 08

Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital

Dec 01

At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?

Sep 15

EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042

Aug 24

Is EC Healthcare (HKG:2138) Using Too Much Debt?

Aug 10

EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042

Jul 14

EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042

Jun 26

Is There Now An Opportunity In EC Healthcare (HKG:2138)?

Jun 15

Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital

May 12

Is EC Healthcare (HKG:2138) Potentially Undervalued?

Mar 08

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

Feb 03

EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year

Dec 20

Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?

Oct 25

EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return

Sep 20

EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

Sep 01

EC Healthcare's (HKG:2138) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 28

EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

Jul 14

EC Healthcare (HKG:2138) Is Reducing Its Dividend To HK$0.042

Jun 26

When Should You Buy EC Healthcare (HKG:2138)?

May 26

EC Healthcare (HKG:2138) Will Be Hoping To Turn Its Returns On Capital Around

Apr 18

Is It Too Late To Consider Buying EC Healthcare (HKG:2138)?

Feb 24

EC Healthcare (HKG:2138) Could Easily Take On More Debt

Feb 11

Opbrengsten en kosten

Hoe EC Healthcare geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

SEHK:2138 Opbrengsten, kosten en inkomsten (HKD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven
31 Mar 24	4,211	-19	599
31 Dec 23	4,157	-11	591
30 Sep 23	4,104	-4	583
30 Jun 23	3,989	33	572
31 Mar 23	3,875	70	560
31 Dec 22	3,622	93	563
30 Sep 22	3,369	117	566
30 Jun 22	3,144	157	496
31 Mar 22	2,920	198	427
31 Dec 21	2,823	253	394
30 Sep 21	2,727	309	361
30 Jun 21	2,404	251	342
31 Mar 21	2,080	193	322
31 Dec 20	1,854	163	243
30 Sep 20	1,627	133	165
30 Jun 20	1,788	210	191
31 Mar 20	1,949	287	217
31 Dec 19	2,023	325	281
30 Sep 19	2,098	364	344
30 Jun 19	1,975	363	361
31 Mar 19	1,852	361	377
31 Dec 18	1,715	355	360
30 Sep 18	1,578	348	344
30 Jun 18	1,450	314	322
31 Mar 18	1,322	279	301
31 Dec 17	1,253	266	271
30 Sep 17	1,183	253	241
30 Jun 17	1,079	227	214
31 Mar 17	975	201	187
31 Dec 16	878	170	169
30 Sep 16	780	139	152
30 Jun 16	744	144	137
31 Mar 16	708	149	123
31 Dec 15	688	166	122
30 Sep 15	668	183	120
30 Jun 15	645	179	116
31 Mar 15	621	174	111
31 Mar 14	490	81	107

Kwaliteitswinsten: 2138 is momenteel verliesgevend.

Groeiende winstmarge: 2138 is momenteel verliesgevend.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: 2138 is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 39.3% per jaar.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van 2138 over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: 2138 is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Consumer Services industrie ( 4.6% ).

Rendement op eigen vermogen

Hoge ROE: 2138 heeft een negatief Return on Equity ( 0.65% ), omdat het momenteel verliesgevend is.

EC Healthcare Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

EC Healthcare to Report First Half, 2025 Results on Nov 28, 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

Full year 2024 earnings: EPS and revenues miss analyst expectations

EC Healthcare to Report Fiscal Year 2024 Results on Jun 27, 2024

First half 2024 earnings released: EPS: HK$0.006 (vs HK$0.068 in 1H 2023)

EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023

Recent updates

New minor risk - Market cap size

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

EC Healthcare to Report First Half, 2025 Results on Nov 28, 2024

Ec Healthcare Provides Sales Expectations for Six Months Ended 30 September 2024

Price target increased by 35% to HK$2.84

Less than half of directors are independent

Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding

EC Healthcare Provides Group Earnings Guidance for the Period from 1 April 2024 to 30 June 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively

Full year 2024 earnings: EPS and revenues miss analyst expectations

EC Healthcare, Annual General Meeting, Aug 23, 2024

EC Healthcare to Report Fiscal Year 2024 Results on Jun 27, 2024

An undisclosed buyer entered into an agreement to acquire additional 51% stake in Preeminent Medical Centre Limited from EC Healthcare (SEHK:2138) for HKD 80.2 million.

EC Healthcare (HKG:2138) Surges 25% Yet Its Low P/S Is No Reason For Excitement

When Should You Buy EC Healthcare (HKG:2138)?

Is EC Healthcare (HKG:2138) A Risky Investment?

New minor risk - Share price stability

EC Healthcare (SEHK:2138) entered into sale and purchase agreement to acquire 6.49% stake in Pangenia Inc from Sharp Point Consultant Limited for HKD 17.4 million.

Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch

EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005

EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023

Price target decreased by 15% to HK$5.22

First half 2024 earnings released: EPS: HK$0.006 (vs HK$0.068 in 1H 2023)

Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital

EC Healthcare Declares an Interim Dividend for the Six Months Ended 30 September 2023, Payable on January 19, 2024

Ec Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2023

EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023

EC Healthcare Announces Executive Changes

At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?

Ec Healthcare Approves Dividend for the Year Ended 31 March 2023, Payment Date Is 18 September 2023

Upcoming dividend of HK$0.042 per share at 2.6% yield

EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042

Ec Healthcare Approves Final Dividend for the Year Ended 31 March 2023

Is EC Healthcare (HKG:2138) Using Too Much Debt?

New minor risk - Earnings quality

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042

Consensus EPS estimates fall by 31%

EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042

Price target decreased by 11% to HK$8.03

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

EC Healthcare, Annual General Meeting, Aug 23, 2023

EC Healthcare Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023

Is There Now An Opportunity In EC Healthcare (HKG:2138)?

EC Healthcare to Report Fiscal Year 2023 Final Results on Jun 23, 2023

Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital

Is EC Healthcare (HKG:2138) Potentially Undervalued?

EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends

Price target increased to HK$9.33

Price target increased to HK$8.04

Upcoming dividend of HK$0.058 per share

EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year

Investor sentiment improved over the past week

Consensus forecasts updated

First half 2023 earnings released

EC Healthcare Announces Interim Dividend for the Six Months Ended 30 September 2022, Payable on 20 January 2023

Price target decreased to HK$8.89

Less than half of directors are independent

EC Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2022

EC Healthcare to Report Q2, 2023 Results on Nov 24, 2022

Investor sentiment improved over the past week

Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?

Price target decreased to HK$10.17

Investor sentiment deteriorated over the past week

EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return

Chairman & Co-CEO recently bought HK$587k worth of stock

EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042

EC Healthcare Announces Executive Changes